drugset / Trial / NCT01256151

Pharmacokinetics Of Alprazolam Sublingual Tablet Versus Conventional Tablet

NCT01256151

Phase 1 Completed 28 enrolled Viatris Inc.
RandomizedCrossoverOpen-labelBasic science

Summary

To assess if the sublingual tablet will have similar pharmacokinetics as the conventional tablet of alprazolam.

Timeline

Start
2011-01
Primary completion
2011-05
Completion
2011-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Alprazolam Small molecule 1 mg Other

Indications